Russell Investments Group, Ltd. Wave Life Sciences Ltd. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,250 shares of WVE stock, worth $18,750. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,250

Previous 3,325 62.41%

Holding current value

$18,750

Previous $16,000 37.5%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$5.12 - $9.01 $10,624 - $18,695	-2,075 Reduced 62.41%	1,250 $10,000
Q2 2024 Aug 08, 2024	BUY	$4.38 - $6.48 $10,152 - $15,020	2,318 Added 230.19%	3,325 $16,000
Q1 2024 May 08, 2024	BUY	$3.54 - $6.84 $3,564 - $6,887	1,007 New	1,007 $6,000
Q2 2022 Jul 29, 2022	SELL	$1.23 - $3.25 $15,416 - $40,735	-12,534 Closed	0 $0
Q1 2022 May 05, 2022	SELL	$2.0 - $3.28 $7,352 - $12,057	-3,676 Reduced 22.68%	12,534 $24,000
Q4 2021 Jan 21, 2022	SELL	$3.14 - $5.15 $17,141 - $28,113	-5,459 Reduced 25.19%	16,210 $50,000
Q3 2021 Nov 08, 2021	SELL	$4.89 - $7.12 $1,623 - $2,363	-332 Reduced 1.51%	21,669 $105,000
Q2 2021 Aug 04, 2021	SELL	$5.65 - $7.47 $12,215 - $16,150	-2,162 Reduced 8.95%	22,001 $145,000
Q1 2021 May 10, 2021	SELL	$5.61 - $12.01 $331,382 - $709,430	-59,070 Reduced 70.97%	24,163 $135,000
Q4 2020 Feb 08, 2021	SELL	$6.99 - $9.26 $27,694 - $36,688	-3,962 Reduced 4.54%	83,233 $653,000
Q3 2020 Nov 09, 2020	BUY	$8.49 - $19.54 $168,458 - $387,712	19,842 Added 29.46%	87,195 $740,000
Q2 2020 Aug 05, 2020	BUY	$7.44 - $11.29 $178,969 - $271,580	24,055 Added 55.56%	67,353 $700,000
Q1 2020 May 06, 2020	BUY	$6.94 - $14.22 $300,488 - $615,697	43,298 New	43,298 $405,000

Others Institutions Holding WVE

# of Institutions

164

Shares Held

116M

Call Options Held

148K

Put Options Held

109K

View Full List

About Wave Life Sciences Ltd.

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $1.3B
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

More about WVE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Wave Life Sciences Ltd. Transaction History